107 related articles for article (PubMed ID: 11937336)
1. Synthesis of (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) derivatives modified at the carbamoyl moiety as a new class of NMDA receptor antagonists.
Kazuta Y; Tsujita R; Ogawa K; Hokonohara T; Yamashita K; Morino K; Matsuda A; Shuto S
Bioorg Med Chem; 2002 Jun; 10(6):1777-91. PubMed ID: 11937336
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of derivatives of (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity.
Kazuta Y; Tsujita R; Yamashita K; Uchino S; Kohsaka S; Matsuda A; Shuto S
Bioorg Med Chem; 2002 Dec; 10(12):3829-48. PubMed ID: 12413836
[TBL] [Abstract][Full Text] [Related]
3. (1S,2R)-1-Phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC), a new class of NMDA-receptor antagonist: molecular design by a novel conformational restriction strategy.
Shuto S; Yoshii K; Matsuda A
Jpn J Pharmacol; 2001 Mar; 85(3):207-13. PubMed ID: 11325012
[TBL] [Abstract][Full Text] [Related]
4. Conformational analysis of the NMDA receptor antagonist (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) designed by a novel conformational restriction method based on the structural feature of cyclopropane ring.
Ono S; Ogawa K; Yamashita K; Yamamoto T; Kazuta Y; Matsuda A; Shuto S
Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):966-8. PubMed ID: 12130856
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of conformationally restricted analogues of milnacipran: (1S, 2R)-1-phenyl-2-[(R)-1-amino-2-propynyl]-N,N- diethylcyclopropanecarboxamide is a novel class of NMDA receptor channel blocker.
Shuto S; Ono S; Imoto H; Yoshii K; Matsuda A
J Med Chem; 1998 Aug; 41(18):3507-14. PubMed ID: 9719604
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of conformationally restricted analogs of milnacipran: (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxami de, an efficient noncompetitive N-methyl-D-aspartic acid receptor antagonist.
Shuto S; Ono S; Hase Y; Ueno Y; Noguchi T; Yoshii K; Matsuda A
J Med Chem; 1996 Nov; 39(24):4844-52. PubMed ID: 8941398
[TBL] [Abstract][Full Text] [Related]
7. Open channel block of NMDA receptors by conformationally restricted analogs of milnacipran and their protective effect against NMDA-induced neurotoxicity.
Noguchi T; Ishii K; Ohtubo Y; Shuto S; Ono S; Matsuda A; Yoshii K
Synapse; 1999 Feb; 31(2):87-96. PubMed ID: 10024005
[TBL] [Abstract][Full Text] [Related]
8. (+/-)-(Z)-2-(aminomethyl)-1-phenylcyclopropanecarboxamide derivatives as a new prototype of NMDA receptor antagonists.
Shuto S; Takada H; Mochizuki D; Tsujita R; Hase Y; Ono S; Shibuya N; Matsuda A
J Med Chem; 1995 Jul; 38(15):2964-8. PubMed ID: 7636857
[TBL] [Abstract][Full Text] [Related]
9. Establishment of CHO cell lines expressing four N-methyl-D-aspartate receptor subtypes and characterization of a novel antagonist PPDC.
Uchino S; Watanabe W; Nakamura T; Shuto S; Kazuta Y; Matsuda A; Nakajima-Iijima S; Kudo Y; Kohsaka S; Mishina M
FEBS Lett; 2001 Oct; 506(2):117-22. PubMed ID: 11591383
[TBL] [Abstract][Full Text] [Related]
10. trans-2-Aryl-N,N-dipropylcyclopropylamines: synthesis and interactions with 5-HT(1A) receptors.
Vallgårda J; Appelberg U; Arvidsson LE; Hjorth S; Svensson BE; Hacksell U
J Med Chem; 1996 Mar; 39(7):1485-93. PubMed ID: 8691479
[TBL] [Abstract][Full Text] [Related]
11. Synaptic strength at the temporoammonic input to the hippocampal CA1 region in vivo is regulated by NMDA receptors, metabotropic glutamate receptors and voltage-gated calcium channels.
Aksoy-Aksel A; Manahan-Vaughan D
Neuroscience; 2015 Nov; 309():191-9. PubMed ID: 25791230
[TBL] [Abstract][Full Text] [Related]
12. Involvement of N-methyl-D-aspartate receptor subunits in zinc-mediated modification of CA1 long-term potentiation in the developing hippocampus.
Takeda A; Itagaki K; Ando M; Oku N
J Neurosci Res; 2012 Mar; 90(3):551-8. PubMed ID: 22057830
[TBL] [Abstract][Full Text] [Related]
13. Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.
Tamiya J; Dyck B; Zhang M; Phan K; Fleck BA; Aparicio A; Jovic F; Tran JA; Vickers T; Grey J; Foster AC; Chen C
Bioorg Med Chem Lett; 2008 Jun; 18(11):3328-32. PubMed ID: 18445525
[TBL] [Abstract][Full Text] [Related]
14. Selective subunit antagonists suggest an inhibitory relationship between NR2B and NR2A-subunit containing N-methyl-D: -aspartate receptors in hippocampal slices.
Mallon AP; Auberson YP; Stone TW
Exp Brain Res; 2005 Apr; 162(3):374-83. PubMed ID: 15580338
[TBL] [Abstract][Full Text] [Related]
15. Activation of NMDA receptors is necessary for the induction of associative long-term potentiation in area CA1 of the rat hippocampal slice.
Murphy KP; Reid GP; Trentham DR; Bliss TV
J Physiol; 1997 Oct; 504 ( Pt 2)(Pt 2):379-85. PubMed ID: 9365912
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction.
Benveniste M; Mayer ML
Br J Pharmacol; 1991 Sep; 104(1):207-21. PubMed ID: 1686203
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
[TBL] [Abstract][Full Text] [Related]
18. Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.
Kazuta Y; Hirano K; Natsume K; Yamada S; Kimura R; Matsumoto S; Furuichi K; Matsuda A; Shuto S
J Med Chem; 2003 May; 46(10):1980-8. PubMed ID: 12723960
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as antagonists of the NMDA receptor-channel complex.
Grauert M; Bechtel WD; Ensinger HA; Merz H; Carter AJ
J Med Chem; 1997 Aug; 40(18):2922-30. PubMed ID: 9288174
[TBL] [Abstract][Full Text] [Related]
20. Metabotropic glutamate receptor dependent EPSP and EPSP-spike potentiation in area CA1 of the submerged rat hippocampal slice.
Breakwell NA; Rowan MJ; Anwyl R
J Neurophysiol; 1996 Nov; 76(5):3126-35. PubMed ID: 8930260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
